IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening
Marcel Pohly(ETH Zurich), Thorsten Zenz(Universität Ulm), Tobias Wertheimer(Memorial Sloan Kettering Cancer Center), Beat Bornhäuser(University Children's Hospital Zurich), Thi Huong Lan(University Hospital Zurich), Karsten Bach(Roche (Switzerland)), Jan Michler(ETH Zurich), Wolfgang Huber(European Molecular Biology Laboratory), Kerstin Putzker(European Molecular Biology Organization), W. Wei‐Lynn Wong(Johns Hopkins University), Joe Lewis(Affimed Therapeutics (Germany)), Andreas E. Moor(Weizmann Institute of Science), Burkhard Becher(University of Zurich), Sebastian Scheinost(German Cancer Research Center), Jarno Kivioja(University Hospital Zurich), Kristina Handler(ETH Zurich), Sandra Kummer(University Hospital Zurich), Junyan Lu(Heidelberg University), Samanta Kisele(University Children's Hospital Zurich), Tatjana Walther(German Cancer Research Center), James Kim(University Children's Hospital Zurich), Minqi Lin(University of Zurich), Sascha Dietrich(Heidelberg University), Lena Ben Taarit(National Center for Tumor Diseases), Xenia Ficht(ETH Zurich)
Cited by 2
Related Papers
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Single-cell multi-omics analysis of the immune response in COVID-19
|Nature Medicine|2021|826